SHARPE
Reported results
- Net income to common stockholders Q3 2026: $446.0 million ($1.14 per diluted share) vs. Q3 2025: $511.0 million ($1.28 per diluted share)
- Non-GAAP operating income Q3 2026: $456.5 million ($1.17 per diluted share) vs. Q3 2025: $440.2 million ($1.10 per diluted share)
- Insurance segment pre-tax underwriting income Q3 2026: $237.7 million, growing 10.6% year-over-year
- Net investment income Q3 2026: $383.5 million with core portfolio increase of 12.0% vs. Q3 2025: $351.2 million
- GAAP combined ratio Q3 2026: 90.8% (current accident year combined ratio before catastrophe losses: 88.1%); gross and net premiums written for Insurance segment grew 4.9% and 3.2%, respectively
- Nine-month net income to common stockholders 2026: $1,413.5 million ($3.60 per diluted share) vs. 2025: $1,329.9 million ($3.32 per diluted share)
Notes
Operating income is a non-GAAP measure excluding after-tax net investment gains (losses) and related expenses and after-tax net foreign currency gains (losses). Company returned $728.6 million to shareholders year-to-date including $435.1 million in share repurchases.
Price and volatility reaction
The stock moved -1.3% on the print. No front-expiry chain was on file, so there is no straddle expected move.
| Measure | Value | Basis |
|---|---|---|
| Close before release | 74.08 | 2026-10-19 |
| Close after release | 73.15 | 2026-10-20 |
| Realised move | -1.3% | close to close |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-19 (8-K, Item 2.02). Read the original filing on sec.gov.